Althea Group Holdings Limited (ASX:AGH)
Australia · Delayed Price · Currency is AUD 0.0240
0.00 (0.00%)
Aug 7, 2025, 1:02 PM AEST
Revance Therapeutics Market Cap
Althea Group Holdings has a market cap or net worth of 20.29 million as of August 6, 2025. Its market cap has increased by 87.37% in one year.
Market Cap
20.29M
Enterprise Value
26.69M
Revenue
27.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since September 21, 2018, Althea Group Holdings's market cap has decreased from 113.85M to 20.29M, a decrease of -82.18%. That is a compound annual growth rate of -22.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 19.74M | 27.81% |
| Dec 29, 2023 | 15.45M | -29.93% |
| Dec 30, 2022 | 22.04M | -68.64% |
| Dec 31, 2021 | 70.30M | -36.38% |
| Dec 31, 2020 | 110.49M | 26.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 129.38B |
| Pro Medicus | 33.04B |
| Cochlear | 20.52B |
| Sonic Healthcare | 13.66B |
| Ramsay Health Care | 8.66B |
| Telix Pharmaceuticals | 6.27B |
| Ansell | 4.43B |
| Mesoblast | 3.08B |